You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
24 December 2025 - Precision oncology company Repare Therapeutics Inc (Nasdaq: RPTX) announced on Wednesday that it has entered into a definitive asset purchase agreement with Gilead Sciences Inc for the sale of its polymerase theta ATPase inhibitor ...
24 December 2025 - R&D driven, AI-powered biopharma company Sanofi (Euronext Paris: SAN) (Nasdaq: SNY) announced on Wednesday that it has agreed to acquire Dynavax Technologies Corporation (Nasdaq: DVAX) in an all-cash transaction valued at appro...
24 December 2025 - Pharmaceutical companies Italfarmaco S.p.A. and JCR Pharmaceuticals Co, Ltd (TSE 4552) on Wednesday announced an exclusive licensing agreement granting JCR Pharmaceuticals rights to develop and commercialise givinostat in Japan for...
23 December 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) and US biotechnology company Regeneron Pharmaceuticals Inc (Nasdaq:REGN) on Tuesday announced approval from Japan's Ministry of Health, Labour and Welfare...
23 December 2025 - Clinical-stage immunotherapeutics company Aqualung Therapeutics announced on Monday that it has received approval from the US Food and Drug Administration (FDA) for a Phase 2a study of ALT-100 mAb as an anti-inflammatory and anti-f...
23 December 2025 - BrioHealth Solutions, a US-based company developing the BrioVAD System, a Left Ventricular Assist Device (LVAD), announced on Monday that the 100th participant has been enrolled in the system's INNOVATE Trial.Launched in late ...
22 December 2025 - Finland-based biopharmaceutical company Faron Pharmaceuticals Ltd (AIM:FARN) (First North:FARON) announced on Monday that it has finalised agreements to initiate the Phase I/II BLAZE trial through a strategic collaboration with The...